These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22306416)

  • 1. Exploring the structure requirement for PKCθ inhibitory activity of pyridinecarbonitrile derivatives: an in silico analysis.
    Li Y; Hao M; Ren H; Zhang S; Wang X; Ma M; Li G; Yang L
    J Mol Graph Model; 2012 Apr; 34():76-88. PubMed ID: 22306416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First generation 5-vinyl-3-pyridinecarbonitrile PKCtheta inhibitors.
    Niu C; Boschelli DH; Tumey LN; Bhagirath N; Subrath J; Shim J; Wang Y; Wu B; Eid C; Lee J; Yang X; Brennan A; Chaudhary D
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5829-32. PubMed ID: 19762237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined 3D-QSAR, molecular docking, and molecular dynamics study on piperazinyl-glutamate-pyridines/pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.
    Hao M; Li Y; Wang Y; Yan Y; Zhang S; Li G; Yang L
    J Chem Inf Model; 2011 Oct; 51(10):2560-72. PubMed ID: 21923153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of in silico models for pyrazoles and pyrimidine derivatives as cyclin-dependent kinase 2 inhibitors.
    Wang F; Ma Z; Li Y; Zhu S; Xiao Z; Zhang H; Wang Y
    J Mol Graph Model; 2011 Sep; 30():67-81. PubMed ID: 21763166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical studies of QSAR and molecular design on a novel series of ethynyl-3-quinolinecarbonitriles as SRC inhibitors.
    Fang DQ; Wu WJ; Zhang R; Zeng GH; Zheng KC
    Chem Biol Drug Des; 2012 Jul; 80(1):134-47. PubMed ID: 22429605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-QSAR studies of JNK1 inhibitors utilizing various alignment methods.
    Madhavan T; Chung JY; Kothandan G; Gadhe CG; Cho SJ
    Chem Biol Drug Des; 2012 Jan; 79(1):53-67. PubMed ID: 21722320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of tricyclic piperazine/piperidine furnished molecules as novel integrin αvβ3/αIIbβ3 dual antagonists using 3D-QSAR and molecular docking.
    Yan Y; Li Y; Zhang S; Ai C
    J Mol Graph Model; 2011 Feb; 29(5):747-62. PubMed ID: 21273104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of 5-phenyl-3-pyridinecarbonitriles as PKCtheta inhibitors.
    Boschelli DH; Wang D; Prashad AS; Subrath J; Wu B; Niu C; Lee J; Yang X; Brennan A; Chaudhary D
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3623-6. PubMed ID: 19447612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR and molecular docking studies of 2-pyrimidinecarbonitrile derivatives as inhibitors against falcipain-3.
    Potshangbam AM; Tanneeru K; Reddy BM; Guruprasad L
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7219-23. PubMed ID: 22018459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding site analysis of CCR2 through in silico methodologies: docking, CoMFA, and CoMSIA.
    Kothandan G; Gadhe CG; Madhavan T; Cho SJ
    Chem Biol Drug Des; 2011 Jul; 78(1):161-74. PubMed ID: 21294847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Vinyl-3-pyridinecarbonitrile inhibitors of PKCtheta: optimization of enzymatic and functional activity.
    Tumey LN; Bhagirath N; Brennan A; Brooijmans N; Lee J; Yang X; Boschelli DH
    Bioorg Med Chem; 2009 Dec; 17(23):7933-48. PubMed ID: 19884013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors.
    Zeng H; Zhang H
    J Mol Graph Model; 2010 Aug; 29(1):54-71. PubMed ID: 20471293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition mechanism exploration of quinoline derivatives as PDE10A inhibitors by in silico analysis.
    Wu Q; Gao Q; Guo H; Li D; Wang J; Gao W; Han C; Li Y; Yang L
    Mol Biosyst; 2013 Mar; 9(3):386-97. PubMed ID: 23354020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitors.
    Cole DC; Asselin M; Brennan A; Czerwinski R; Ellingboe JW; Fitz L; Greco R; Huang X; Joseph-McCarthy D; Kelly MF; Kirisits M; Lee J; Li Y; Morgan P; Stock JR; Tsao DH; Wissner A; Yang X; Chaudhary D
    J Med Chem; 2008 Oct; 51(19):5958-63. PubMed ID: 18783200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling studies on imidazo[4,5-b]pyridine derivatives as Aurora A kinase inhibitors using 3D-QSAR and docking approaches.
    Lan P; Chen WN; Chen WM
    Eur J Med Chem; 2011 Jan; 46(1):77-94. PubMed ID: 21093113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and PKCtheta inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitriles.
    Dushin RG; Nittoli T; Ingalls C; Boschelli DH; Cole DC; Wissner A; Lee J; Yang X; Morgan P; Brennan A; Chaudhary D
    Bioorg Med Chem Lett; 2009 May; 19(9):2461-3. PubMed ID: 19345579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
    Kamath S; Buolamwini JK
    J Med Chem; 2003 Oct; 46(22):4657-68. PubMed ID: 14561085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.